In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | S-1/A | S-1/A |
Cash flows from Operating Activities: | | | |
Net loss | 21.0 | 80.1 | 33.0 |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Change in fair value of warrants | -23.7 | | |
Changes in operating assets and liabilities: | | | |
Accrued expenses and other liabilities | 11.9 | | |
Net cash provided by (used in) operating activities | -1.2 | 46.5 | 32.7 |
|
Cash flows from Investing Activities: | | | |
Net cash used in investing activities | | 136.6 | -85.4 |
|
Cash flows from Financing Activities: | | | |
Proceeds from related-party loan | 0.5 | | |
Net cash used in financing activities | 0.5 | -128.1 | 26.1 |
|
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets: | | | |
Cash and cash equivalents | | | |
Restricted cash | | | |
Supplemental cash flow information: | | | |
Cash paid for operating lease liabilities | | | |
ROU assets obtained in exchange for operating lease liabilities | | | |
Capitalized assets financed by accounts payable | | | |
Stock-based compensation included in capitalized software development costs | | | |
Settlement of incentive plan through issuance of common stock | | | |
Equity issuance to settle intercompany loan | | | |
Deferred consideration for acquisition | | | |